Long-term follow-up study of patients with adrenal incidentalomas
- PMID: 12370111
- DOI: 10.1530/eje.0.1470489
Long-term follow-up study of patients with adrenal incidentalomas
Abstract
Background: The incidence of adrenal incidentalomas has sharply increased in recent decades and concurrent subtle endocrine abnormalities, or even subclinical conditions, have been identified. Nonetheless, data concerning possible changes in adrenal size and/or hormonal pattern during follow-up are still inadequate.
Objective: To evaluate long-term morphological and functional evolution of adrenal incidentalomas after initial diagnosis and to identify possible risk factors for hormonal hyperactivity and mass enlargement.
Patients: Sixty-four patients (34-79 years) were followed-up for 12-120 months (median 25.5 months). Initial computerized tomography scan showed a unilateral mass in 51 patients and bilateral lesions in 13 patients. Average mass diameter at diagnosis was 2.5+/-0.1 cm (range 1.0-4.0). Twelve patients had subclinical Cushing's syndrome, 41 had mild hormonal alterations, and 11 had normal adrenal function at baseline. All patients were investigated by morphological and functional evaluation 6 and 12 months after diagnosis, and then at 1-year intervals.
Results: During follow-up, a mass size increase >/=1 cm was observed in 13 patients, and 18 developed further subtle endocrine alterations. Cumulative risk of developing endocrine abnormalities was 17% at 1 year, 29% at 2 years, and 47% at 5 years. The risk was higher in the first 2 years of follow-up if the initial tumor diameter was >or=3 cm. Overall, cumulative risk of mass enlargement was 6% at 1 year, 14% at 2 years, and 29% at 5 years, and it was greater in patients with normal adrenal function than in those with subtle hormonal abnormalities (P<0.05). One female subject showed a mass enlargement after 6 months of follow-up and was eventually diagnosed with non-Hodgkin's lymphoma.
Conclusions: Patients with an adrenal incidentaloma are at risk for tumor growth and development of hormonal alterations. The risk of adrenal malignancy, although not elevated, also indicates the need for long-term follow-up.
Similar articles
-
Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.Clin Endocrinol (Oxf). 2009 May;70(5):674-9. doi: 10.1111/j.1365-2265.2008.03492.x. Clin Endocrinol (Oxf). 2009. PMID: 19067718
-
Risk factors and long-term follow-up of adrenal incidentalomas.J Clin Endocrinol Metab. 1999 Feb;84(2):520-6. doi: 10.1210/jcem.84.2.5444. J Clin Endocrinol Metab. 1999. PMID: 10022410
-
Subclinical Cushing's syndrome in adrenal incidentaloma.Clin Endocrinol (Oxf). 1998 Jan;48(1):89-97. doi: 10.1046/j.1365-2265.1998.00357.x. Clin Endocrinol (Oxf). 1998. PMID: 9509073
-
Cushing's disease with a unilateral adrenal macronodule: evolutive transition or incidental finding?South Med J. 1993 Feb;86(2):235-8. doi: 10.1097/00007611-199302000-00021. South Med J. 1993. PMID: 8434302 Review.
-
Adrenal mild hypercortisolism.Endocrinol Metab Clin North Am. 2015 Jun;44(2):371-9. doi: 10.1016/j.ecl.2015.02.009. Endocrinol Metab Clin North Am. 2015. PMID: 26038206 Review.
Cited by
-
Clinical Features of 50 Patients With Primary Adrenal Lymphoma.Front Endocrinol (Lausanne). 2020 Sep 24;11:595. doi: 10.3389/fendo.2020.00595. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33071959 Free PMC article.
-
Hormonal activity in clinically silent adrenal incidentalomas.Arch Med Sci. 2012 Feb 29;8(1):97-103. doi: 10.5114/aoms.2012.27288. Arch Med Sci. 2012. PMID: 22457682 Free PMC article.
-
Clinical outcomes of surgical treatment and longitudinal non-surgical observation of patients with subclinical Cushing's syndrome and nonfunctioning adrenocortical adenoma.Indian J Urol. 2012 Apr;28(2):179-83. doi: 10.4103/0970-1591.98461. Indian J Urol. 2012. PMID: 22919134 Free PMC article.
-
Multidisciplinary approach for patients with functional and non-functional adrenal masses and review of the literature.Health Sci Rep. 2017 Dec 20;1(3):e22. doi: 10.1002/hsr2.22. eCollection 2018 Mar. Health Sci Rep. 2017. PMID: 30623061 Free PMC article.
-
Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.Endocrine. 2021 Jan;71(1):178-188. doi: 10.1007/s12020-020-02476-1. Epub 2020 Sep 11. Endocrine. 2021. PMID: 32915435 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical